Dose and safety concerns of clozapine: Worldwide package inserts need revisions

Jose de Leon; Can Jun Ruan; Georgios Schoretsanitis; John M. Kane

doi:10.1016/j.schres.2019.12.009

Dose and safety concerns of clozapine: Worldwide package inserts need revisions

Jose de Leon
, Can Jun Ruan
, Georgios Schoretsanitis
, John M. Kane

Research output: Contribution to journal › Comment/debate

30 Scopus citations

Original language	English
Pages (from-to)	2-4
Number of pages	3
Journal	Schizophrenia Research
Volume	216
DOIs	https://doi.org/10.1016/j.schres.2019.12.009
State	Published - Feb 2020

Bibliographical note

Funding Information:
The authors acknowledge Lorraine Maw, M.A., at the Mental Health Research Center at Eastern State Hospital, Lexington, Kentucky, who helped in editing this article. Dr. Ruan is supported by a 2019 NARSAD Young Investigator Award. The authors are grateful to the reviewers who provided important suggestions for improving the article.

Funding Information:
The authors acknowledge Lorraine Maw, M.A. at the Mental Health Research Center at Eastern State Hospital, Lexington, Kentucky, who helped in editing this article. Dr. Ruan is supported by a 2019 NARSAD Young Investigator Award. The authors are grateful to the reviewers who provided important suggestions for improving the article.

Funding

The authors acknowledge Lorraine Maw, M.A., at the Mental Health Research Center at Eastern State Hospital, Lexington, Kentucky, who helped in editing this article. Dr. Ruan is supported by a 2019 NARSAD Young Investigator Award. The authors are grateful to the reviewers who provided important suggestions for improving the article. The authors acknowledge Lorraine Maw, M.A. at the Mental Health Research Center at Eastern State Hospital, Lexington, Kentucky, who helped in editing this article. Dr. Ruan is supported by a 2019 NARSAD Young Investigator Award. The authors are grateful to the reviewers who provided important suggestions for improving the article.

Funders
Lorraine Maw
National Alliance for Research on Schizophrenia and Depression

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Clozapine/metabolism
Clozapine/pharmacokinetics
Drug interaction
Drug labeling
Infection
Inflammation
Myocarditis
Pneumonia

ASJC Scopus subject areas

Psychiatry and Mental health
Biological Psychiatry

Access to Document

10.1016/j.schres.2019.12.009

Cite this

@article{25e65f6f584c44649907d10252dda25d,

title = "Dose and safety concerns of clozapine: Worldwide package inserts need revisions",

keywords = "Clozapine/metabolism, Clozapine/pharmacokinetics, Drug interaction, Drug labeling, Infection, Inflammation, Myocarditis, Pneumonia",

author = "\{de Leon\}, Jose and Ruan, \{Can Jun\} and Georgios Schoretsanitis and Kane, \{John M.\}",

note = "Funding Information: The authors acknowledge Lorraine Maw, M.A., at the Mental Health Research Center at Eastern State Hospital, Lexington, Kentucky, who helped in editing this article. Dr. Ruan is supported by a 2019 NARSAD Young Investigator Award. The authors are grateful to the reviewers who provided important suggestions for improving the article. Funding Information: The authors acknowledge Lorraine Maw, M.A. at the Mental Health Research Center at Eastern State Hospital, Lexington, Kentucky, who helped in editing this article. Dr. Ruan is supported by a 2019 NARSAD Young Investigator Award. The authors are grateful to the reviewers who provided important suggestions for improving the article.",

year = "2020",

month = feb,

doi = "10.1016/j.schres.2019.12.009",

language = "English",

volume = "216",

pages = "2--4",

}

TY - JOUR

T1 - Dose and safety concerns of clozapine

T2 - Worldwide package inserts need revisions

AU - de Leon, Jose

AU - Ruan, Can Jun

AU - Schoretsanitis, Georgios

AU - Kane, John M.

N1 - Funding Information: The authors acknowledge Lorraine Maw, M.A., at the Mental Health Research Center at Eastern State Hospital, Lexington, Kentucky, who helped in editing this article. Dr. Ruan is supported by a 2019 NARSAD Young Investigator Award. The authors are grateful to the reviewers who provided important suggestions for improving the article. Funding Information: The authors acknowledge Lorraine Maw, M.A. at the Mental Health Research Center at Eastern State Hospital, Lexington, Kentucky, who helped in editing this article. Dr. Ruan is supported by a 2019 NARSAD Young Investigator Award. The authors are grateful to the reviewers who provided important suggestions for improving the article.

PY - 2020/2

Y1 - 2020/2

KW - Clozapine/metabolism

KW - Clozapine/pharmacokinetics

KW - Drug interaction

KW - Drug labeling

KW - Infection

KW - Inflammation

KW - Myocarditis

KW - Pneumonia

UR - https://www.scopus.com/pages/publications/85077649732

UR - https://www.scopus.com/pages/publications/85077649732#tab=citedBy

U2 - 10.1016/j.schres.2019.12.009

DO - 10.1016/j.schres.2019.12.009

M3 - Comment/debate

C2 - 31926811

AN - SCOPUS:85077649732

SN - 0920-9964

VL - 216

SP - 2

EP - 4

JO - Schizophrenia Research

JF - Schizophrenia Research

ER -

Dose and safety concerns of clozapine: Worldwide package inserts need revisions

Bibliographical note

Funding

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this